IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea
- Written by PR Newswire
- Potential new treatment option for multiple myeloma patients in Korea.
- Expanded patient access through competitive pricing.
SHANGHAI and NANJING, China and PLEASANTON, Calif., Oct. 29, 2025 /PRNewswire/ -- Nanjing IASO Biotechnology ("IASO Bio"), today announced that it has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy...
Read more: IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea














